Obsessive Compulsive Disorder Studies
Obsessive Compulsive Disorder
Phase 2-4Active
Key Facts
Indication
Obsessive Compulsive Disorder
Phase
Phase 2-4
Status
Active
About Noesis Pharma Clinical Trials
NoesisPharma is a private, physician-owned clinical research site founded in 2010 (with operational data suggesting 2015) and based in Phoenix, Arizona. The company provides clinical trial services for Phase II-IV studies, with a core therapeutic focus on psychiatry and CNS disorders. Led by its founder and Medical Director, Dr. Lee Ann Kelley, the organization leverages a team with decades of combined clinical and research experience to conduct trials for external biopharma sponsors, operating under a fee-for-service business model.
View full company profileTherapeutic Areas
Other Obsessive Compulsive Disorder Drugs
| Drug | Company | Phase |
|---|---|---|
| OCD Clinical Trials | Boston Clinical Trials | Not Specified (Typically Phase 2-3) |
| NBS System 6 for OCD | Nexstim | Approved |
| TMS for OCD | Magstim | Commercial/Clinical Development |